News

A Georgia compounding pharmacy has recalled 40 lots of injection syringes containing bevacizumab (Avastin, Genentech/Roche) after five patients developed intraocular infections.

The Vitra Multispot laser (Quantel Medical) has received a 510(k) market clearance from the FDA. It is intended to deliver a cost-effective solution to ophthalmologists dealing with epidemic levels of diabetic eye disease.

The final module of the premarket approval application (PMA) for the Kamra corneal inlay to treat presbyopia has been submitted to the FDA by AcuFocus, the inlay’s manufacturer.

Normal-tension glaucoma (NTG) is a very complex disease. There seem to be both IOP-dependent and IOP-independent mechanisms. David Greenfield, MD, outlines his four-point strategy for managing NTG.

Jerry A. Shields, MD, director of the Wills Eye Ocular Oncology Service, has been named to receive the National Physician of the Year Award in Clinical Excellence.

Going digital

Unlock the potential of digital spectacle lenses for your patients, dispensary

In the following video, Mark Forchette, president and CEO of OptiMedica, discusses how the FDA approval of the Catalys femtosecond laser for creating single-plane and multi-plane arc incisions during cataract surgery, and its subsequent market launch, means to the company.